BCE, Inc. Common Stock (BCE)

Financing Cash Flow

-$2.38B

TTM · Period ending: · CAD

BCE logo

BCE Financing Cash Flow

Latest reported-$2.38B CAD
BCE TTM Cash from Financing · CAD (-$181.95M → -$2.38B)
High-resolution chart · PNG

BCE financing cash flow history

Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.

BCE, Inc. Common Stock Financing Cash Flow — Trailing twelve months (TTM) (CAD)
Period endingFinancing Cash Flow (CAD)
-2,384,018,641
-2,188,180,678
-4,111,359,680
-4,792,098,580
-4,623,098,580
-2,563,321,280
-1,379,918,800
-417,408,899
-620,091,499
-1,690,868,799
-1,220,911,599
-1,615,810,300
-1,358,127,700
-1,597,127,700
-2,804,127,700
-2,844,000,000
-2,135,714,000
-3,265,714,000
-1,070,714,000
-2,964,714,000
-3,953,000,000
-4,584,000,000
-4,135,000,000
-3,434,000,000
-4,003,000,000
-1,930,000,000
-4,202,000,000
-3,698,000,000
-2,740,000,000
-3,832,000,000
-3,198,000,000
-3,824,000,000
-3,140,000,000
-2,754,000,000
-2,149,000,000
-1,246,000,000
-1,194,000,000
-545,000,000
-1,819,000,000
-1,349,000,000
-2,147,000,000
-2,983,000,000
-2,113,000,000
-2,906,000,000
-2,254,000,000
-1,716,000,000
-2,440,000,000
-2,118,000,000
-1,898,000,000
-868,000,000
131,000,000
925,000,000
-67,000,000
-629,000,000
-1,507,000,000
-2,092,000,000
-1,767,000,000
-3,042,000,000
-1,581,000,000
-679,000,000
-938,000,000
315,000,000
-1,400,000,000
-2,222,000,000
-2,802,000,000
-3,479,000,000
-4,044,000,000
-3,667,717,973
-2,745,129,002
-2,076,579,424
-1,556,580,864
-2,894,167,973
-3,647,133,936
-3,814,957,985
-3,913,993,445
-3,893,859,717
-1,956,178,473
-2,292,004,248
-3,012,581,547
-2,077,759,247
-3,556,817,074
-3,009,866,805
-1,563,430,357
-1,745,507,982
-1,531,453,409
-2,018,509,386
-2,189,824,814
-3,123,673,629
-3,394,843,014
-4,151,985,195
-2,948,602,344
-1,497,195,189
1,708,803,013
3,457,813,951
3,434,459,015
3,515,568,209
980,733,972
366,331,771
-1,838,990,447
-82,196,228
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.